Reaction

Aphagia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,820 reports · 76 co-occurring drugs

As of the last recalculation, Aphagia appears in 4,820 FAERS reports alongside 76 co-occurring drug terms. The strongest observed disproportionality signal is SORAFENIB (PRR 24.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Sorafenib	117	24.9	25.0
Esomeprazole Magnesium	882	19.7	19.8
Regorafenib	36	13.5	13.5
Interferon Beta-1B	43	9.8	9.8
Sunitinib Malate	78	8.7	8.7
Dimethyl Fumarate	168	6.1	6.1
Extended Phenytoin Sodium	23	6.0	6.0
Rivastigmine	23	5.3	5.3
Ribavirin	75	5.1	5.1
Promethazine Hydrochloride	20	4.7	4.7
Drospirenone And Ethinyl Estradiol	47	4.6	4.6
Peginterferon Alfa-2A	57	4.6	4.6
Quetiapine	193	4.5	4.5
Carisoprodol	19	4.3	4.3
Rifampicin	10	4.3	4.3
Phytonadione	8	4.1	4.1
Interferon Beta-1A	177	4.1	4.1
Captopril	9	4.0	4.1
Natalizumab	162	3.9	4.0
Lapatinib	14	3.9	3.9
Lisinopril And Hydrochlorothiazide Tablets	7	3.9	3.9
Erlotinib Hydrochloride	11	3.8	3.8
Dicyclomine Hydrochloride	12	3.6	3.6
Omeprazole Magnesium	346	3.5	3.5
Valsartan And Hydrochlorothiazide	11	3.5	3.5
Everolimus	41	3.5	3.5
Anastrozole	29	3.4	3.4
Ezetimibe And Simvastatin	12	3.4	3.4
Lisinopril And Hydrochlorothiazide	8	3.4	3.4
Tolterodine Tartrate	7	3.4	3.4
Cetuximab	24	3.3	3.3
Quinapril Hydrochloride	6	3.3	3.3
Felodipine Extended-Release Tablets	8	3.0	3.0
Felodipine	8	3.0	3.0
Zoledronic Acid	28	3.0	3.0
Asenapine Maleate	6	3.0	3.0
Loperamide Hydrochloride And Dimethicone	22	3.0	3.0
Deferasirox	18	2.9	2.9
Fluticasone Propionate And Salmeterol	28	2.9	2.9
Desvenlafaxine Succinate	17	2.7	2.7
Imatinib Mesylate	17	2.6	2.6
Lovastatin	15	2.5	2.5
Dabigatran Etexilate Mesylate	42	2.5	2.5
Levodopa	7	2.5	2.5
Dabigatran Etexilate	44	2.5	2.5
Ziprasidone Mesylate	8	2.4	2.4
Sofosbuvir	11	2.4	2.4
Cisplatin	39	2.2	2.2
Tobramycin Solution	6	2.2	2.2
Capecitabine	45	2.1	2.1
Aprepitant	9	2.1	2.1
Tobramycin Sulfate	6	2.1	2.1
Varenicline Tartrate	38	2.1	2.1
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	14	1.9	1.9
Agalsidase Beta	4	1.9	1.9
Armodafinil	9	1.8	1.8
Pazopanib Hydrochloride	11	1.8	1.8
Liraglutide	20	1.8	1.8
Fentanyl Citrate	7	1.7	1.7
Dofetilide	4	1.6	1.6
Buprenorphine Hydrochloride, Naloxone Hydrochloride	9	1.6	1.6
Fesoterodine Fumarate	4	1.6	1.6
Vigabatrin	5	1.5	1.5
Bosutinib	3	1.4	1.4
Vilazodone Hydrochloride	3	1.4	1.4
Daptomycin	3	1.4	1.4
Crizotinib	4	1.4	1.4
Erlotinib	3	1.3	1.3
Axitinib	6	1.3	1.3
Dornase Alfa	6	1.3	1.3
Vemurafenib	3	1.1	1.1
Cortisone Acetate	3	1.0	1.0
Botulinum Toxin Type A	3	1.0	1.0
Hydrocodone Bitartrate	10	1.0	1.0
Orlistat	5	0.8	0.8
Levonorgestrel	22	0.5	0.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.